Showing 481-498 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Vaccines for preventing tick‐borne encephalitis
Cochrane Systematic Reviews, 21-Jan-2009
Tick-borne encephalitis (TBE) is a disease of the central nervous system caused by a tick-borne viral infection. TBE can lead to severe neurological syndromes such as meningitis, meningoencephalitis, and meningoencephalomyelitis, which can result in death
- Vagus nerve stimulation for partial seizures
Cochrane Systematic Reviews, 3-Apr-2015
Vagus nerve stimulation (VNS) is a neuromodulatory treatment that is used as an adjunctive therapy for treating people with medically refractory epilepsy. VNS consists of chronic intermittent electrical stimulation of the vagus nerve, delivered by a progr
- Validation therapy for dementia
Cochrane Systematic Reviews, 21-Jul-2003
Validation therapy was developed by Naomi Feil between 1963 and 1980 for older people with cognitive impairments. Initially, this did not include those with organically-based dementia, but the approach has subsequently been applied in work with people who
- Valproate preparations for agitation in dementia
Cochrane Systematic Reviews, 5-Oct-2018
Agitation has been reported in up to 90% of people with dementia. Agitation in people with dementia worsens carer burden, increases the risk of injury, and adds to the need for institutionalisation. Valproate preparations have been used in an attempt to c
- Velnacrine for Alzheimer's disease
Cochrane Systematic Reviews, 12-May-2008
Alzheimer's disease (AD) is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in relevant parts of
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
Cochrane Systematic Reviews, 13-Jan-2015
This is an update of a Cochrane review first published in The Cochrane Library in Issue 4, 2007 and previously updated in 2011.
- Vigabatrin versus carbamazepine monotherapy for epilepsy
Cochrane Systematic Reviews, 18-Nov-2015
This is an update of a Cochrane review first published in 2012 (Cochrane Database of Systematic Reviews 2012, Issue 1).
- Vinpocetine for cognitive impairment and dementia
Cochrane Systematic Reviews, 20-Jan-2003
Vinpocetine is a synthetic ethyl ester of apovincamine, a vinca alkaloid obtained from the leaves of the Lesser Periwinkle (Vinca minor) and discovered in the late 1960s. Although used in human treatment for over twenty years, it has not been approved by
- Vitamin B12 for cognition
Cochrane Systematic Reviews, 21-Jul-2003
An association between neuropsychiatric disorders and vitamin B12 deficiency has been recognized since 1849 when pernicious anaemia was first described. It has been suggested that deficiency of vitamin B12 might contribute to age-associated cognitive impa
- Vitamin B6 for cognition
Cochrane Systematic Reviews, 12-May-2008
Micronutrient status can affect cognitive function at all ages. Vitamin deficiencies could influence memory function and might contribute to age-associated cognitive impairment and dementia. Vitamin B6, comprising three chemically distinct compounds, pyri
- Vitamin D for the management of multiple sclerosis
Cochrane Systematic Reviews, 24-Sep-2018
This review is an update of a previously published review, "Vitamin D for the management of multiple sclerosis" (published in the Cochrane Library; 2010, Issue 12). Multiple sclerosis (MS) is characterised by inflammation, demyelination, axonal or neurona
- Vitamin E for Alzheimer's dementia and mild cognitive impairment
Cochrane Systematic Reviews, 18-Apr-2017
Vitamin E occurs naturally in the diet. It has several biological activities, including functioning as an antioxidant to scavenge toxic free radicals. Evidence that free radicals may contribute to the pathological processes behind cognitive impairment has
- Vitamin E for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 17-Jan-2018
Antipsychotic (neuroleptic) medication is used extensively to treat people with chronic mental illnesses. Its use, however, is associated with adverse effects, including movement disorders such as tardive dyskinesia (TD) – a problem often seen as repetiti
- Vitamins for epilepsy
Cochrane Systematic Reviews, 10-Aug-2009
Vitamins have been reported to be effective in controlling certain types of seizures and to prevent some of the harmful effects of antiepileptic drugs (AEDs). In this review we will summarize evidence from randomized controlled trials.
- Yizhi capsule for vascular dementia
Cochrane Systematic Reviews, 18-Apr-2007
Vascular dementia (VD) is a syndrome or diagnosis that has different causes and clinical manifestations relating to several different vascular mechanisms and changes in the brain. Some traditional Chinese herbal medicines were developed for treating VD. Y
- Yoga for epilepsy
Cochrane Systematic Reviews, 5-Oct-2017
This is an updated version of the original Cochrane Review published in the Cochrane Library, Issue 5, 2015.
- Zhiling decoction for vascular dementia
Cochrane Systematic Reviews, 5-May-2008
Zhiling decoction has a fixed composition of 15 Chinese herbs. The properties of each of these herbs and in combination provide the therapeutic rationale for a possible action of Zhiling decoction in dilating cerebral vessels and increasing cerebral blood
- Zonisamide add‐on therapy for focal epilepsy
Cochrane Systematic Reviews, 24-Jul-2020
The majority of people with epilepsy have a good prognosis, and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop dug-resistant epilepsy, especially those with focal seizures. In this review, we summ
